2011 Anniversary Yearbook - EUFEPS today and history

More documents

Recommendations

Info

EUFEPS Newsletter, 1992, vol. 1, issue 2 Dear Members, successful first EUFEPS Congress Hans Junginger, Professor President of the Organizing Scientific Committee Following the establishment in 1991 of the European Federation for Pharmaceutical Sciences, one of the first aims of the Society was to bring together pharmaceutical scientists and to organize a truly scientific congress in one of the member countries. The Dutch Association for Pharmaceutical Sciences is honoured to arrange the First European Congress of Pharmaceutical Sciences, to take place in Amsterdam at the RAI-Congress Center, during October 7–9, 1992. As chairman of the Scientific Committee, I am pleased to announce that we succeeded in attracting 39 leading scientists from primarily European countries, and covering all pharmaceutical disciplines, who will contribute to 12 symposia and present the results of their latest research. Already two weeks before the deadline for submitting the abstracts for poster presentation, we had received more than 100 abstracts. This clearly indicates that the congress will, in fact, be an accepted meeting place of scientists from all over the world. I would therefore like to encourage you, too, to participate in the Congress. Amsterdam is today a modem metropolis which houses the dynamic RAI Amsterdam Convention Center. The Dutch capital has succeeded in combining its contemporary character with the unique historical atmosphere of the 17th century inner city and its famous system of canals. It is my sincere hope IV Hans Junginger, Professor that all those attending the First European Congress will be able to enjoy the exciting dualism of this city, blending the serious work of acquiring the latest information and research results from all branches of the pharmaceutical sciences with the delightful experience of being captured by the intimate allure of the streets, squares and canals of this fascinating place. What a superb environment in which to attend a very important Congress, to relax and to make new friends, and to experience the charm of Amsterdam! With best regards,
EUFEPS Newsletter, 1992, vol. 1, issue 3 The Future of Pharmaceutical Sciences Douwe D. Breimer, Professor EUFEPS Vice-President Pharmaceutical sciences may traditionally be regarded as conglomerate of various disciplines, each of which deals with a certain aspect of biologically active molecules and each of which was considered essential for the training and education of pharmacist. In fact such disciplines were defined as belonging to pharmaceutical sciences because they were undertaken in the context of a faculty of a college or pharmacy, although some flourished more in dependently in faculties of medicine (e.g. pharmacology) or natural sciences (e.g. biochemistry). Research was mostly of a monodisciplinary nature and strongest in fields like pharmaceutics and pharmaceutical technology, pharmaceutical chemistry, pharmacognosy and drug analysis. In the 60s and 70s, biopharmaceutics, pharmacokinetics and drug metabolism began to flower and the development of specific and sensitive analytical methodology made it possible for pharmaceutical sciences to become more involved in biological experimentation, including in vivo studies in laboratory animals and man. New fields of interest developed, borders flanking the biomedical sciences were crossed. However, despite the fact that these new areas of research have given a new impetus to pharmaceutical sciences and have contributed to a better recognition of pharmaceutical research in general, the newer fields still tend to develop in a monodisciplinary way. The major challenges in pharmaceutical research today are not associated with one discipline only, but with several at the same time. This requires multidisciplinary approaches, as illustrated by a few examples, all of which constitute major objectives of drug research: • new drug molecule design based on cloned receptors and molecular graphics, in relation to mechanisms and origins of disease; • drug delivery system design, based on physicochemical principles, and with rates and time specifications based on pharmacodynamic and pharmacokinetic considerations; • drug targeting, primarily based on (patho) physiological, (patho) biochemical and ilmmunological principles and only secondarily on principles derived from pharmaceutical technology; • application of products originating from biotechnology (proteins and other macromolecules), by non-parenteral routes of administration based on the principles of membrane biochemistry and cell biology; • individualization and, thereby, optimization of drug therapy based on new methodologies in characterizing metabolizing enzyme activities (deficiencies) in vivo and new methodologies in quantifying and monitoring pharmacological effects; • assessment and prediction of drug (xenobiotic) toxicity and adverse reactions based on insight into (molecular) mechanisms of drug toxicity, e.g. as related to drug metabolism. All these subjects require integrated approaches, both at the molecular level and at the higher organizational levels of living organisms, with the ultimate goal of unifying all information towards the in vivo human situation. Such approaches are all at the interface between chemical/ physical and biological/biomedical sciences. It is this unifying and V Douwe D. Breimer, Professor integrating concept that holds the future of pharmaceutical sciences. Whenever monodisciplinary considerations continue to prevail, the risk of disintegration is near at hand. The synergistic additional value of being part of a conglomerate of interacting disciplines should be utilized and fully explored. This will give rise to most important implications for drug discovery, drug delivery, and improved and more rational drug therapy. It is in this spirit that EUFEPS will organize its biannual European Congresses of Pharmaceutical Sciences, as was illustrated just recently by the first Congress in Amsterdam.
Page 1 and 2:
EUFEPS Yearbook 2011 20 th Annivers
Page 3 and 4:
cal Sciences 2001 2002 2003 2004 20
Page 6 and 7: Pharma Ingredients & Services Custo
Page 8 and 9: The Gamlen Tablet Press The world
Page 10 and 11: Sustainable sponsorship of EUFEPS g
Page 12 and 13: 2. PRESIDENT’S INTRODUCTION Democ
Page 14 and 15: 4. Member Societies Academy of Phar
Page 16 and 17: Croatian Pharmaceutical Society - C
Page 18 and 19: Hellenic Society of Medicinal Chemi
Page 20 and 21: Norwegian Pharmaceutical Society No
Page 22 and 23: Romanian Society of Pharmaceutical
Page 24 and 25: Swedish Swedish Academy Academy of
Page 26 and 27: 5. Individual Memberships Represent
Page 28 and 29: B. The membership terminates: • i
Page 30 and 31: K. The Executive Director shall •
Page 32 and 33: 7. Executive Committee 2010-2011 EU
Page 34 and 35: 8. Advisory Committees Committee on
Page 36 and 37: 9. EUFEPS Networks Scope and aim Th
Page 38 and 39: Network Environment and Pharmaceuti
Page 40 and 41: 10. Awards and Prizes EUFEPS is, si
Page 42 and 43: The New Safe Medicines Faster Award
Page 44 and 45: 12. The Pharmaceutical Sciences Fai
Page 46 and 47: 14. EUFEPS in EU Projects Since est
Page 48 and 49: 16. EUFEPS on the Global Scene Sinc
Page 50 and 51: 17. Sponsorship Recognition The cor
Page 52 and 53: Selection of articles from the EUFE
Page 54 and 55: EUFEPS Newsletter, 1992, vol. 1, is
Page 64 and 65: Frankfurt. CIR consists of a core g
Page 66 and 67: Objective 5 To enhance the recognit
Page 68 and 69: that they have reached the conclusi
Page 70 and 71: The procedure is safe and of relati
Page 78 and 79: EUFEPS Newsletter, 2001, vol. 10, i
Page 80 and 81: XXVIII
Page 86 and 87: paradigm shift regarding the qualit
Page 92 and 93: professionals into academia, indust
Page 106 and 107:
EUFEPS Newsletter, 2006, vol. 15, i
Page 108 and 109:
Page 110 and 111:
ecomes an issue’ in Verona (2006)
Page 112 and 113:
on which “Theology, Jurisprudence
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
important steps towards a comprehen
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
and set up their “own” programm
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
show all

2011 Anniversary Yearbook - EUFEPS today and history

Create successful ePaper yourself

Delete template?

Save as template?